Cassava Sciences Gross Margin 2011-2025 | SAVA

Current and historical gross margin for Cassava Sciences (SAVA) over the last 10 years. The current gross profit margin for Cassava Sciences as of September 30, 2025 is %.

Cassava Sciences Gross Margin Historical Data
Date	TTM Revenue	TTM Gross Profit	Gross Margin
2013-12-31	$0.04B	$0.04B	100.00%
2013-09-30	$0.01B	$0.01B	100.00%
2013-06-30	$0.01B	$0.01B	100.00%
2013-03-31	$0.01B	$0.01B	100.00%
2012-12-31	$0.01B	$0.01B	100.00%
2012-09-30	$0.01B	$0.01B	100.00%
2012-06-30	$0.01B	$0.01B	100.00%
2012-03-31	$0.01B	$0.01B	100.00%
2011-12-31	$0.01B	$0.01B	100.00%
2011-09-30	$0.02B	$0.02B	100.00%
2011-06-30	$0.02B	$0.02B	100.00%
2011-03-31	$0.02B	$0.02B	100.00%
2010-12-31	$0.02B	$0.02B	100.00%
2010-09-30	$0.01B	$0.01B	100.00%
2010-06-30	$0.01B	$0.01B	100.00%
2010-03-31	$0.02B	$0.02B	100.00%
2009-12-31	$0.02B	$0.02B	100.00%
2009-09-30	$0.03B	$0.03B	100.00%
2009-06-30	$0.05B	$0.05B	100.00%
2009-03-31	$0.06B	$0.06B	100.00%
2008-12-31	$0.06B	$0.06B	100.00%
2008-09-30	$0.07B	$0.07B	100.00%
2008-06-30	$0.06B	$0.06B	100.00%
2008-03-31	$0.06B	$0.06B	100.00%
2007-12-31	$0.07B	$0.07B	100.00%
2007-09-30	$0.06B	$0.06B	100.00%
2007-06-30	$0.06B	$0.06B	100.00%
2007-03-31	$0.06B	$0.06B	100.00%
2006-12-31	$0.05B	$0.05B	100.00%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.152B	$0.000B
Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$88.891B	33.76
Zoetis (ZTS)	United States	$51.852B	18.56
Takeda Pharmaceutical (TAK)	Japan	$45.789B	9.34
Daiichi Sankyo, - (DSNKY)	Japan	$41.088B	20.46
BeOne Medicines - (ONC)	Switzerland	$38.031B	186.54
Sandoz Group AG (SDZNY)	Switzerland	$32.740B	0.00
United Therapeutics (UTHR)	United States	$21.034B	18.51
Merck (MKKGY)	Germany	$18.174B	11.20
Neurocrine Biosciences (NBIX)	United States	$15.429B	37.02
Shionogi (SGIOY)	Japan	$14.530B	13.34
Summit Therapeutics (SMMT)	United States	$13.873B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$12.976B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.819B	0.00
IPSEN (IPSEY)	France	$11.918B	0.00
Orion OYJ (ORINY)	Finland	$9.738B	27.82
Corcept Therapeutics (CORT)	United States	$9.165B	99.01
Eisai (ESAIY)		$8.627B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.590B	36.88
Grifols, S.A (GRFS)	Spain	$6.298B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.238B	18.97
Crinetics Pharmaceuticals (CRNX)	United States	$4.679B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.544B	0.00
NewAmsterdam Pharma (NAMS)	Netherlands	$4.101B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.851B	18.28
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.654B	0.00
Ocular Therapeutix (OCUL)	United States	$3.125B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.820B	9.00
Hypermarcas (HYPMY)	Brazil	$2.787B	19.13
Dyne Therapeutics (DYN)	United States	$2.774B	0.00
Soleno Therapeutics (SLNO)	United States	$2.658B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.094B	24.81
Avadel Pharmaceuticals (AVDL)	Ireland	$2.089B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.974B	38.01
Harrow (HROW)	United States	$1.893B	116.14
BioCryst Pharmaceuticals (BCRX)	United States	$1.596B	94.75
Collegium Pharmaceutical (COLL)	United States	$1.529B	7.57
Oruka Therapeutics (ORKA)	United States	$1.462B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.435B	0.00
Ardelyx (ARDX)	United States	$1.434B	0.00
Savara (SVRA)	United States	$1.412B	0.00
Relay Therapeutics (RLAY)	United States	$1.350B	0.00
Xencor (XNCR)	United States	$1.218B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.163B	0.00
Enliven Therapeutics (ELVN)	United States	$1.114B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.109B	0.00
Evotec AG (EVO)	Germany	$1.090B	0.00
Cronos Group (CRON)	Canada	$1.090B	0.00
Nektar Therapeutics (NKTR)	United States	$1.040B	0.00
Esperion Therapeutics (ESPR)	United States	$0.975B	0.00
Theravance Biopharma (TBPH)	United States	$0.896B	37.62
KalVista Pharmaceuticals (KALV)	United States	$0.854B	0.00
Aquestive Therapeutics (AQST)	United States	$0.771B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.763B	6.82
Lexeo Therapeutics (LXEO)	United States	$0.715B	0.00
Lyell Immunopharma (LYEL)	United States	$0.710B	0.00
ProKidney (PROK)	United States	$0.668B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.624B	0.00
Bioventus (BVS)	United States	$0.614B	12.58
Organogenesis (ORGO)	United States	$0.605B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.599B	14.15
Elite Pharmaceuticals (ELTP)	United States	$0.558B	0.00
Altimmune (ALT)	United States	$0.557B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.472B	0.00
Siga Technologies (SIGA)	United States	$0.467B	6.39
Akebia Therapeutics (AKBA)	United States	$0.441B	0.00
Nature's Sunshine Products (NATR)	United States	$0.388B	23.09
USANA Health Sciences (USNA)	United States	$0.375B	10.45
Galectin Therapeutics (GALT)	United States	$0.368B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.364B	0.00
Avalo Therapeutics (AVTX)	United States	$0.354B	0.00
Larimar Therapeutics (LRMR)	United States	$0.333B	0.00
Fractyl Health (GUTS)	United States	$0.315B	0.00
OmniAb (OABI)	United States	$0.311B	0.00
Relmada Therapeutics (RLMD)	United States	$0.307B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.304B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.276B	0.00
Pyxis Oncology (PYXS)	United States	$0.275B	0.00
Heron Therapeutics (HRTX)	United States	$0.251B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.250B	0.00
Protara Therapeutics (TARA)	United States	$0.232B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.231B	0.00
Profound Medical (PROF)	Canada	$0.224B	0.00
MediWound (MDWD)	Israel	$0.214B	0.00
Journey Medical (DERM)	United States	$0.211B	0.00
AleAnna (ANNA)	United States	$0.205B	0.00
Surrozen (SRZN)	United States	$0.204B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.170B	0.00
Innate Pharma SA (IPHYF)	France	$0.160B	0.00
Gain Therapeutics (GANX)	United States	$0.158B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.158B	0.00
Incannex Healthcare (IXHL)	Australia	$0.141B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.138B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.119B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.115B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.108B	0.00
Avita Medical (RCEL)	United States	$0.108B	0.00
Prelude Therapeutics (PRLD)	United States	$0.102B	0.00
Vivani Medical (VANI)	United States	$0.101B	0.00
Plus Therapeutics (PSTV)	United States	$0.099B	0.00
Context Therapeutics (CNTX)	United States	$0.096B	0.00
VAXART, INC (VXRT)	United States	$0.088B	0.00
Champions Oncology (CSBR)	United States	$0.087B	31.50
Acrivon Therapeutics (ACRV)	United States	$0.082B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.079B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.078B	0.00
Rafael Holdings (RFL)	United States	$0.077B	0.00
Dominari Holdings (DOMH)	United States	$0.076B	0.00
Assertio Holdings (ASRT)	United States	$0.076B	0.00
Korro Bio (KRRO)	United States	$0.074B	0.00
Lite Strategy (LITS)	United States	$0.067B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.067B	0.00
Metagenomi (MGX)	United States	$0.065B	0.00
PolyPid (PYPD)	Israel	$0.063B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.062B	0.00
Arch Biopartners (ACHFF)	Canada	$0.061B	0.00
Nutriband (NTRB)	United States	$0.060B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.057B	0.00
Wellgistics Health (WGRX)	United States	$0.056B	0.00
Talphera (TLPH)	United States	$0.055B	0.00
Century Therapeutics (IPSC)	United States	$0.052B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.051B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.041B	0.00
ElectroCore (ECOR)	United States	$0.039B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.037B	31.12
Mural Oncology (MURA)	Ireland	$0.035B	0.00
FibroGen (FGEN)	United States	$0.035B	0.00
Klotho Neurosciences (KLTO)	United States	$0.031B	0.00
Inotiv (NOTV)	United States	$0.028B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
Vyome Holdings (HIND)	United States	$0.027B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.025B	0.00
Scienture Holdings (SCNX)	United States	$0.025B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.024B	0.00
Liminatus Pharma (LIMN)	United States	$0.023B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.023B	0.00
TherapeuticsMD (TXMD)	United States	$0.021B	0.00
Natural Alternatives (NAII)	United States	$0.020B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.020B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Traws Pharma (TRAW)	United States	$0.019B	0.02
Lipocine (LPCN)	United States	$0.018B	0.00
Mannatech (MTEX)	United States	$0.017B	0.00
Mangoceuticals (MGRX)	United States	$0.016B	0.00
Cosmos Health (COSM)	United States	$0.016B	0.00
Tempest Therapeutics (TPST)	United States	$0.016B	0.00
Heatwurx (PCSA)	United States	$0.015B	0.00
BioLineRx (BLRX)	Israel	$0.014B	0.00
VYNE Therapeutics (VYNE)	United States	$0.013B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
BioVie (BIVI)	United States	$0.011B	0.00
Ainos (AIMD)	United States	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.010B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.010B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.010B	0.00
Aptorum Group (APM)	United Kingdom	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.007B	0.00
Lyra Therapeutics (LYRA)	United States	$0.007B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
ProPhase Labs (PRPH)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Jaguar Animal Health (JAGX)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.004B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
CDT Equity (CDT)	United States	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Aditxt (ADTX)	United States	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Indivior (INDV)	United States	$0.000B	18.26
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Minerva Neurosciences (NERV)	United States	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00